MedTrace Logo

Newborn Screening for Congenital Heart Disease

NCT01665261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6730

Last updated 2015-03-11

No results posted yet for this study

Summary

The purpose of this study is to test the accuracy of 7 indicators in screening congenital heart defects (CHD) in all newborns (symptomatic or asymptomatic) to determine whether these indicators could be applied in the nationwide newborn CHD screening. The investigator's hypothesis is that 7 indicators are effective in neonate CHD screening with the acceptable accuracy.

Conditions

  • Congenital Heart Disease

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Huang G Ying, MD PHD · Children's Hospital of Fudan University

Eligibility

Min Age
6 Hours
Max Age
72 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-09-30
Completion
2013-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01665261 on ClinicalTrials.gov